Viscosupplementation Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Australia, Singapore, Brazil, Mexico, Saudi Arabia, South Africa), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Report ID: GMI4212
Viscosupplementation Market size is projected to experience significant growth from 2019 to 2025.
Viscosupplementation is a procedure used for treatment of medical conditions such as knee osteoarthritis, shoulder osteoarthritis, hip osteoarthritis, spine arthritis and ankle arthritis. In this procedure a lubricating fluid is injected into the defected joint in order to treat the symptoms of arthritis. The lubricating fluid is usually administered through hyaluronic acid injection or hyaluronan injection.
The global viscosupplementation market is projected to expand at a lucrative CAGR owing to growing adoption of minimally invasive procedures, rising global prevalence of knee osteoarthritis and the increasing ageing population. A rise in osteoarthritis cases will boost the demand for viscosupplementation. For instance, according to the Arthritis Foundation, over 30 million Americans suffer from osteoarthritis out of which 13% women and 10% men aged 60 years and above have symptomatic knee osteoarthritis.
Amongst the geriatric population, knee osteoarthritis is one of the leading causes for physical disability. With the rise in the global average age, there will be growth in prevalence of knee osteoarthritis. Patients suffering from diabetes, obesity, renal failure, hypertension, gastrointestinal bleeding, cardiovascular diseases, trauma in joints and depression are subject to high risk due to knee osteoarthritis. Abovementioned factors will drive the global viscosupplementation market over the foreseeable future.
Women are more vulnerable for osteoarthritis in comparison to men. Rising cases of injuries, increasing prevalence of tobacco smoking habits, changing lifestyles and poor nutrition are factors that lead to osteoarthritis and osteoporosis amongst masses. Aforementioned reasons will augment the global viscosupplementation market growth.
The government of several countries across the globe provide medical cover through reimbursing partial or full cost of medical treatment as well as diagnosis. Such facilities are provided under various health insurance policies that are aimed to assist citizen with their healthcare spending. A rise in volume of such initiatives by government all over the world will result in augmenting growth of the global viscosupplementation market over the forecast period.
Moreover, advancement in healthcare technology along with rising adoption of viscosupplementation by end-users are major factors driving the global viscosupplementation market growth. However, the growth of viscosupplementation market will be hindered by stringent regulatory approvals regarding usage of this procedure over the forecast period.
The three-injection procedure segment is expected to show promising growth over the forecast period. This growth is attributed to low cost in comparison to single-injection procedure and lower hospital visits in comparison to five-injection procedure. Hospitals is expected to be the largest segment by end-use due to highest patient footfall, presence of skilled medical professionals and large infrastructure.
The highest share by country of the global viscosupplementation market is held by the U.S. in 2018. This high share is attributed to the sophisticated healthcare infrastructure, skilled medical professionals, increasing adoption for advanced medical procedures as well as presence of key market players in the country. China is expected to show promising growth over the forecast period. This growth is attributed to large geriatric population and rising investment in healthcare industry.
Sanofi, Hoffmann-La Roche, Allergan, Smith & Nephew Plc, Zimmer Biomet, Anika Therapeutics Inc., Ferring B.V., Fidia Farmaceutici S.P.A., Regen Lab SA and Bioventus are some of the prominent market players of the global viscosupplementation market. Research and Development, technological advancements, merger, accreditations, capacity expansion and acquisitions account for key strategic initiatives by the market players in order to improve their business portfolio.
Viscosupplementation Market by Procedure, 2014-2025 (USD Million)
- Single Injection Procedure
- Three Injection Procedure
- Five Injection Procedure
Viscosupplementation Market by End-use, 2014-2025 (USD Million)
- Orthopedic Clinics
- Ambulatory Surgical Centers
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Hoffmann-La Roche
- Smith & Nephew Plc
- Zimmer Biomet
- Anika Therapeutics Inc.
- Ferring B.V.
- Fidia Farmaceutici S.P.A.
- Regen Lab SA
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability